ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Markets/EquitiesArticle

Precigen COO sells $375,000 in shares under trading plan

Rutul Shah, COO of Precigen, sold 50,000 shares worth $375,000 on Aug. 21 and 25 under a prearranged 10b5-1 plan. The sales followed option exercises at $2.33 per share.

PA
Priya Anand · Equities & Earnings Desk · 30 Aug 2026 · 23:58 · 1 min read
Share
Precigen COO sells $375,000 in shares under trading plan

Rutul R. Shah, Chief Operating Officer of Precigen Inc., disposed of 50,000 shares of the company’s common stock in two transactions executed on August 21 and August 25, 2026, under a previously adopted Rule 10b5-1 trading plan. The sales totaled approximately $375,000 at a price of $7.50 per share.

The transactions followed Shah’s exercise of 50,000 fully vested stock options at an exercise price of $2.33 per share on the same dates. Additionally, Shah settled 7,500 restricted stock units on August 23, 2026, representing the right to receive an equivalent number of Precigen common shares. Precigen withheld 3,647 shares on August 23 to cover income tax obligations, valued at $7.20 each for a total of about $26,258.

Precigen’s stock closed at $7.28 on August 25, up 1.53% or $0.11, after reaching an intraday high of $7.45 in after-hours trading. The shares remain near the 52-week high of $7.55 and have delivered an 83% annual return, according to InvestingPro data.

The company reported second-quarter earnings of $0.05 per share, beating the expected loss of $0.01, alongside revenue of $54.98 million—nearly double the forecast of $27.83 million—and net income of $20.1 million, marking a return to profitability.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT